We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (P ؍ 0.0361 and P ؍ 0.0237, respectively).
Mycoplasma pneumoniae is a major cause of community-acquired pneumonia (CAP) in school-age children and young adults (1, 2). A specific diagnosis of M. pneumoniae infection is important because treatment with routinely used -lactam antibiotics is ineffective against these organisms because they lack a cell wall. Thus, the Japanese Respiratory Society (JRS) CAP guidelines have been recommended as a rapid and simple scoring system based on clinical and laboratory findings for the presumptive diagnosis of M. pneumoniae pneumonia (1,3,4). Our recent study demonstrated that the JRS scoring system was the most useful tool for initiating the administration of adequate antibiotic therapy for probable M. pneumoniae pneumonia among the rapid diagnostic methods tested (5).Although M. pneumoniae pneumonia is usually mild in severity, macrolide-resistant (MR) M. pneumoniae with mutations in the 23S rRNA gene has emerged in pediatric patients with CAP (6, 7). More than 60% of M. pneumoniae strains in pediatric patients showed high resistance to 14-and 15-membered ring macrolides with a MIC of Ն64 mg/liter (8-10). The clinical and bacteriological efficacy of macrolides for treating cases of MR M. pneumoniae pneumonia was lower than that in cases of macrolide-sensitive (MS) M. pneumoniae pneumonia in pediatric patients (9-13). In contrast to pediatric patients, the available data on MR M. pneumoniae infection in adolescent and adult patients are limited (8,14). The purpose of the present study was to identify a means of rapidly distinguishing MR M. pneumoniae pneumonia from MS M. pneumoniae pneumonia in daily clinical practice without waiting for genetic analysis results. We compared the underlying conditions, pneumonia severity, clinical symptoms, laboratory data, prognostic factors, and radiographic findings between patients with MR M. pneumoniae pneumonia and those with MS M. pneumoniae pneumonia (MR patients and MS patients, respectively) in adolescents and adults. Based on the clinical presentation, we evaluated the usefulness of rapid and simple clinical diagnostic methods (5), the JRS scoring system (1, 3, 4), and high-resolution computed tomography (HRCT) (15, 16) for the early presumptive diagnosis of M. pneumoniae pneumonia. An additional purpose of this study was to investigate the drug susceptibility of MR isolates and differences in therapeutic efficacy against MR M. pneumoniae among macrolides, quinolones, and minocycline.Adolescent and adult patients with CAP who visited 12 i...